Facebook Users

Will STXS go up?

STXS Stereotaxis, Inc. featured news, full reports, and detailed charts

Stereotaxis, Inc. (STXS) Wrap Up:

This annual report on Form 10-K, including the sections entitled “Business” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements. These statements relate to, among other things: • our business strategy; • our value proposition; • the timing and status of review by our collaboration partner of manufacturing and design issues relating to our magnetic irrigated catheter; • the timing and prospects for regulatory approval of our additional disposable interventional devices; • our estimates regarding our capital requirements; • the ability of physicians to perform certain medical procedures with our products safely, effectively and efficiently;   ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f17%2f0001193125-08-058487.html#FIS_BUSINESS"   
www.stereotaxis.com
183 Employees
Founded in 1990

Stereotaxis Inc. (STXS:NASDAQ)

LAST $3.83 USD
CHANGE TODAY -0.09 -2.30%
VOLUME 288.0K
As of 4:00 PM 11/20/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).

Snapshot of Stereotaxis Inc. (STXS)

OPEN
$4.06
PREVIOUS CLOSE
$3.92
DAY HIGH
$4.07
DAY LOW
$3.82
52 WEEK HIGH
08/6/09 - $5.19
52 WEEK LOW
01/27/09 - $2.30
MARKET CAP
192.5M
AVERAGE VOLUME 3 mo
195.6K
DILUTED EPS TTM
$-0.70
SHARES OUTSTANDING
50.3M
STXS Does Not Pay Dividends
P/E TTM
NM
K = Thousands  M = Millions  B = Billions

related news

Safer Surgery With Stereotaxis

STXS Top Compensated Officers

Mr. Michael P. Kaminski
Chief Executive Officer
Age: 49
Total Annual Compensation: $345.0K
Mr. James M. Stolze
Chief Financial Officer, Principal Accounting...
Age: 65
Total Annual Compensation: $310.0K
Mr. Louis T. Ruggiero
Chief Commercial Officer
Age: 49
Total Annual Compensation: $175.0K
Mr. Douglas M. Bruce
Chief Technology Officer
Age: 51
Total Annual Compensation: $295.0K
Ms. Melissa C. Walker MS, RAC
Senior Vice President of Regulatory, Quality ...
Age: 52
Total Annual Compensation: $235.0K

Executives, Board Directors

Compensation as of Fiscal Year 2008.

Key developments for Stereotaxis Inc. (STXS)

Stereotaxis Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2009 ; Provides Revenue Guidance for the Year 2009

Stereotaxis Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company's revenue totaled $13.3 million, an increase of 26% over $10.6 million for the third quarter of 2008. Operating loss was $5.8 million compared with a $10.0 million operating loss in the same period in 2008. The company reported a net loss of $5.8 million, or $0.14 diluted per share. This compared with a net loss of $10.1 million, or $0.28 diluted per share. The increase was due in large part to the issuance of 4.4 million shares as part of two concurrent private placements of stock completed in December 2008. Cash used in operations was $3.5 million compared with $5.5 million in the third quarter of 2008. For the first nine months of 2009, revenue grew 31% to $37.1 million compared with $28.2 million in the first nine months of 2008. Operating loss was $18.0 million compared with a $34.6 million operating loss in the same period in 2008. Net loss was $20.7 million or $0.50 diluted per share compared to $36.3 million or $1.00 diluted per share for the same period a year ago. For the year 2009, the company expects total revenue to exceed 2008 revenue.

Stereotaxis Inc., Q3 2009 Earnings Call, Nov-05-2009

Stereotaxis Inc., Q3 2009 Earnings Call, Nov-05 2009

Stereotaxis Inc. expected to Report Fiscal Year 2009 Results on February 26, 2010. This event was calculated by Capital IQ (Created on October 22, 2009).

Stereotaxis Inc. expected to Report Fiscal Year 2009 Results on February 26, 2010. This event was calculated by Capital IQ (Created on October 22, 2009).

otc, otcbb, pinksheet, STXS, ob Stereotaxis, Inc.

STXS Competitors

Company Last Change
Hansen Medical Inc $2.70 USD +0.05
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation STXS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.0x

STXS

 | 

STXS transactions

Type
Date
Target
No transactions in the last 6 months.

More Recent News About Stereotaxis, Inc.

Would you like to leave a comment about Stereotaxis, Inc. STXS

Besides Stereotaxis, Inc. there is more great information available at Realpennies.com